Recombinant DNA Advisory Committee - 2/10-11/92 
Robert Bosselman, AmGen 
Jan Chappell, Genetic Therapy, Inc. 
Kenneth Cometta, Indiana University 
Susan Dudley, Economists, Inc. 
Bogdan Dziurzynski, Immunex 
Dan Eckstein, NOVA Research Company 
James Economou, University of California, Los Angeles 
Diane Fleming, Merck & Company 
Scott Freeman, University of Rochester Medical Center 
Diane Gershon, Nature Magazine 
Philip Greenberg, University of Washington 
Eva Hedblom, Swedish Embassy 
William Hines, Mouse Trap Farm 
John Jaugstetter, Genentech, Inc. 
Roger Johnson, Genetic Engineering News 
Alexander Kuta, Food and Drug Administration 
Fred Ledley, Howard Hughes Medical Institute 
Craig McCune, University of Rochester 
Gerard McGarrity, Genetic Therapy, Inc. 
Susan Mize, Mize Information Enterprise 
Robert Moen, Genetic Therapy, Inc. 
Jack Moorman, Greenwood Research, Inc. 
Lisa Morris, Genetic Therapy, Inc. 
Sandy Morseth, Food and Drug Administration 
Gary Nabel, University of Michigan 
Chris Plein, University of Missouri 
Jerilyn Probst, Immunex 
Raj Puri, Food and Drug Administration 
Judy Randal, Biotechnology Week 
Reginald Rhein, Biotechnology Newswatch 
Nancy Rhodes, NOVA Research Company 
Stan Riddell, Fred Hutchinson Cancer Research Center 
Doug Roberts, Food and Drug Administration 
Tomiko Shimada, Ambience Awareness, International 
Nina Siegler, Greenwood Research, Inc. 
Junichi Taki, Nikkei, Inc. 
Larry Thompson, The Washington Post 
Guido Tricot, Indiana University 
Deborah Uman, FDC Reports, Inc. 
Elio Vanin, Genetic Therapy, Inc. 
David Wheeler, The Chronicle of Higher Education 
[314] 
Recombinant DNA Research, Volume 15 
